In most dioecious plants, distinguishing male and female progenies is not possible until flowering or fruiting stage. The fig (Ficus carica L.) is such a plant where distinguishing male and female plants at the seedling stage can accelerate fig-breeding programs. An orthologue of RAN1 loci was reported to be associated with sex determination in fig (Mori et al., 2017). The objective of this study is to validate this locus on Turkish fig germplasm collection and F1 population obtained from a cross between female genotypes ‘Bursa Siyahi’ and male genotype ‘Ak Ilek’. A total of 144 genotypes from germplasm collection and 115 F1 individuals were tested with CAPS (cleaved amplified polymorphic sequences) marker following the Mori et al. (2017). The loci produced a 315bp amplification product from all genotypes. PciI digestion of PCR products resulted in 100% concordance between phenotypes and molecular tests. On the other hand, HpyCH4IV enzyme digestion of 8 female genotypes resulted in false negatives among the tested materials. Therefore, despite overall results show that the locus is suitable for gender selection of plants at the seedling stage in the breeding programs, care should be taken when HpyCH4IV enzyme is to be employed for CAPS assay.
*********
In press - Online First. Article has been peer reviewed, accepted for publication and published online without pagination. It will receive pagination when the issue will be ready for publishing as a complete number (Volume 47, Issue 3, 2019). The article is searchable and citable by Digital Object Identifier (DOI). DOI link will become active after the article will be included in the complete issue.
*********
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.